跳至主要内容
临床试验/NCT06416267
NCT06416267尚未招募不适用

Immune Biomarkers, Genetic Risk, and the Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)

University of Haifa0 个研究点目标入组 1,500 人开始时间: 2024年8月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,500
主要终点
Assess the relationship between LC MBL and cardiovascular diseases, autoimmune conditions, and Alzheimer among Jews and Arabs in Israel

研究概览

简要总结

The aim of this proposal is to identify immune biomarkers, genetic risk, and the clinical consequences of low count monoclonal B-cell lymphocytosis (LC MBL), a common premalignant condition affecting up to 17% of European adults age>40. LC MBL is a precursor to chronic lymphocytic leukemia (CLL), characterized by a circulating population of clonal B-cells. It is relatively understudied, despite emerging evidence of clinical consequences such as increased risk for life-threatening infections and lymphoid malignancies. Studies reported that male sex, age, family history of CLL, and CLL-susceptibility genetic loci were associated with LC MBL risk. These findings were reported in European ancestry individuals and have not been generalized to other thnicities. This study will provide this missing knowledge using a unique multi-ethnic Israeli population of Jews and Arabs that have one of the highest and lowest age-standardized incidence rates of CLL in the world, respectively, and characterized with different genetic backgrounds.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals over the age pf 40

排除标准

  • Individuals with lymphoproliferative disorder

结局指标

主要结局

Assess the relationship between LC MBL and cardiovascular diseases, autoimmune conditions, and Alzheimer among Jews and Arabs in Israel

时间窗: From enrollment and 15 years of follow up

Blood samples will be screened for MBL using flow cytometry, while data on the various outcomes will be collected from electronic medical records from Clalit Health Services.

Assess the relationship between LC MBL and life-threatening infections, hematologic malignancies, and solid tumors among Jews and Arabs in Israel

时间窗: From enrollment and 15 years of follow up

Blood samples will be screened for MBL using flow cytometry, while data on the various outcomes will be collected from electronic medical records from Clalit Health Services.

Identify germline genetic factors that are associated with LC MBL risk among Jews and Arabs in Israel

时间窗: The first 5 years of the study

DNA will be extracted from the blood sample and sequenced.

Evaluate the prevalence of LC MBL by Jews and Arabs and by sex in Israel.

时间窗: The first 5 years of the study

Blood samples will be screened for MBL using flow cytometry, ethnicity and sex will be determined using a demographic questionnaire

Identify immune biomarkers that are associated with LC MBL risk

时间窗: The first 5 years of the study

Blood sample will be screened for MBL using flow cytometry, and immune biomarkers will be screened from plasma samples.

次要结局

  • Assess the relationship between LC MBL and other clinical conditions(From enrollment and 15 years of follow up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Geffen Kleinstern

Senior Lecturer

University of Haifa

相似试验